Polypeptide
Polypeptide is a Public Limited Company registered in Belgium under 0879346768, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 14 February 2006 and lists its registered address as Belgium. 1 shareholder is on record for Polypeptide, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Polypeptide
One shareholder is currently on record for Polypeptide, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Polypeptide Laboratories Holding (PPL) AB, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Polypeptide Laboratories Holding (PPL) AB | 100% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
Directors and officers of Polypeptide
The Director of Polypeptide currently on record is TORALF HAAG; five officers are currently on record for Polypeptide, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Polypeptide sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 21 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Polypeptide
Polypeptide sits 6 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands. Immediately above Polypeptide is Polypeptide Laboratories Holding (Ppl) AB, holding 100% as filed in Polypeptide's own shareholder record with Crossroads Bank for Enterprises (KBO/BCE). C&P Investors Limited sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
C&P Investors Limited
British Virgin Islands
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Polypeptide?
One shareholder is currently on record for Polypeptide, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Polypeptide Laboratories Holding (PPL) AB, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Polypeptide's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Polypeptide is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Polypeptide have on record?
1 shareholder is shown on record for Polypeptide.
What is Polypeptide's company registration number?
Polypeptide's registration number is 0879346768, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Polypeptide still an active company?
Polypeptide's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Polypeptide incorporated?
Polypeptide was incorporated on 14 February 2006, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Polypeptide's registered address?
The registered address on file for Polypeptide is Belgium.
What legal structure is Polypeptide registered as?
Polypeptide is registered as a Public Limited Company in Belgium.
Who are the officers/directors of Polypeptide?
The Director of Polypeptide currently on record is TORALF HAAG; five officers are currently on record for Polypeptide, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Polypeptide sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Polypeptide have a parent company or subsidiaries?
Polypeptide sits 6 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands.
Can Zavia monitor changes to Polypeptide's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Polypeptide's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Polypeptide's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Polypeptide's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 28 September 2026.